Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neoplasm Metastasis
Interventions: DRUG: Vinorelbine|DRUG: Gemcitabine
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Eli Lilly and Company